Brian Frezza

Brian Frezza – Co-Founder & Co-CEO

Emerald Therapeutics

Brian M. Frezza is Co-founder and Co-CEO of Emerald Therapeutics, where he spearheads Emerald’s therapeutic research effort and is lead architect of the Emerald Cloud Lab (ECL), a remote controlled life science laboratory. Brian completed his PhD in Chemical Biology at The Scripps Research Institute (TSRI) working on DNA nanotechnology under committee mentorship of Feynman award-winning chemists, M. Reza Ghadiri and Nadrian Seeman. Brian is a Hollerith and Wolfram Innovator award-winner who has received over a hundred combined citations for published articles in the Journal of the American Chemical Society (JACS) and Chemical Physics. He has also served as a peer reviewer for both JACS and Langmuir, and guest-lectured at Carnegie Mellon University, TSRI, and Stanford University.